Take­da’s man­u­fac­tur­ing site in Bel­gium gets a €300M boost for plas­ma ther­a­py pro­duc­tion

While phar­ma gi­ant Take­da has been ex­pand­ing its pres­ence in R&D and man­u­fac­tur­ing through­out the US and Asia over the past year, its lat­est move will see the com­pa­ny mak­ing a nine-fig­ure in­vest­ment in Eu­rope.

Take­da will pump €300 mil­lion ($299 mil­lion) in­to ex­pand­ing its man­u­fac­tur­ing site in Lessines, Bel­gium, a city around 30 miles south­west of Brus­sels. The ex­pan­sion will aim to in­crease the man­u­fac­tur­ing of plas­ma-de­rived ther­a­pies. Take­da al­so said that this is the largest in­vest­ment the com­pa­ny had made in Bel­gium.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER